🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Sponsor trial record
Trackers Companies Trial finder
Sponsor · clinical trials

Gözde Yagci (Gür) clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our Turkey register with Gözde Yagci (Gür) as lead sponsor. Synced 26 Sep 2026
3Current trials
1Recruiting now
0Drugs in these trials
1Trial register
Maintained by Sreepriya Prasannan
MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 — Top 14 finalist
Compiled from ClinicalTrials.gov and CTIS registry records · Last verified · Editorial standards
At a glance

Gözde Yagci (Gür) is the lead sponsor of 3 current clinical trials in our Turkey register. 1 is recruiting patients now. The most common phase is Not applicable. The most-studied condition is Adolescent Idiopathic Scoliosis (AIS).

ClinicalTrials.gov trials by status

  • Recruiting133%
  • Not yet open267%

Trials by phase

  • Not applicable267%
  • Observational133%
01

Clinical trials sponsored by Gözde Yagci (Gür)

3 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
Basic Body Awareness Therapy Added to Scoliosis-Specific Exercise in Adolescents With Scoliosis
NCT07500883 · ClinicalTrials.gov ↗ · Adolescent Idiopathic Scoliosis (AIS)
Not applicable Recruiting 2025-11 Turkey
Effects of Body Awareness Therapy on Posture, Trunk Movement, Scoliosis & Body Awareness in Adolescents With Scoliosis
NCT06855030 · ClinicalTrials.gov ↗ · Adolescent Idiopathic Scoliosis (AIS)
Not applicable Not yet open 2025-04 Turkey
Investigation of Shoulder Position, Upper Extremity Proprioception, and Function in Adolescents With Idiopathic Scoliosis Using Braces
NCT06904157 · ClinicalTrials.gov ↗ · Adolescent Idiopathic Scoliosis (AIS)
Observational Not yet open 2025-04 Turkey

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Conditions in Gözde Yagci (Gür) trials

1 condition
Adolescent Idiopathic Scoliosis (AIS)3
03

By trial register

RegisterTrialsRecruiting
Clinical trials in Turkey31

A trial with sites in more than one country appears in each of those registers.

04

Other sponsors in Adolescent Idiopathic Scoliosis (AIS)

SponsorTrials
Istituto Scientifico Italiano Colonna Vertebrale2

Sponsors with the most current trials registered for this condition.

05

Questions about Gözde Yagci (Gür) trials

How many clinical trials does Gözde Yagci (Gür) sponsor?

Gözde Yagci (Gür) is the lead sponsor of 3 current trials on ClinicalTrials.gov in our Turkey register, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.

Are Gözde Yagci (Gür) trials recruiting?

Yes. 1 of its 3 ClinicalTrials.gov trials is recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Sep 2026.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.